PLoS ONE (Jan 2022)

The efficacy of oxidized regenerated cellulose (SurgiGuard®) in breast cancer patients who undergo total mastectomy with node surgery: A prospective randomized study in 94 patients.

  • Kug Hyun Nam,
  • Joon-Hyop Lee,
  • Yoo Seung Chung,
  • Yong Soon Chun,
  • Heung Kyu Park,
  • Yun Yeong Kim

DOI
https://doi.org/10.1371/journal.pone.0267694
Journal volume & issue
Vol. 17, no. 5
p. e0267694

Abstract

Read online

BackgroundSeromas frequently develop in patients who undergo total mastectomy with node surgery. We aimed to prospectively explore whether use of oxidized regenerated cellulose (ORC, SurgiGuard®) affects seroma formation after total mastectomy with node surgery (sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND)).Materials and methodsNinety four breast cancer patients were enrolled in the study who underwent total mastectomy with ALND or SLNB. The patients were randomized into two groups, one treated with ORC plus closed suction drainage and the other with closed suction drainage alone.ResultsMean drainage volume was slightly lower in the ORC group on postoperative day 1 (123 ± 54 vs 143 ± 104 ml), but was slightly higher at all other time points; however, these differences were not significant. Mean total drainage volume in patients treated with ORC plus drainage did not differ from that of patients treated with drainage alone (1134 ± 507 ml vs 1033 ± 643 ml, P = 0.486).ConclusionsUse of ORC (SurgiGuard®) did not significantly alter the risk of seroma formation.